The first British Ebola patient treated with Chinese medicine mil77 recovered

Source: China Science and Technology Network - Science and technology daily March 30, 2015 a British Ebola patient recently recovered and left the hospital During the treatment, she used the Chinese drug mil77, the first Ebola patient in the world to receive this drug treatment According to British media reports, the patient, Anna Kroos, 25 years old, is a British military medical staff Previously, she volunteered as a nurse in Sierra Leone, the hardest hit area of the Ebola epidemic Unfortunately, she was infected with Ebola, and was sent back to the Royal Free Hospital in northern London for treatment Now she has recovered and discharged from the hospital Experts at the hospital said that Klose, who used the Chinese drug mil77 during the treatment, was the first Ebola patient in the world to receive the "experimental drug" treatment However, it is not clear how much role the drug played in her recovery, and the exact efficacy of the drug remains to be further confirmed In addition, in the first issue of 2015, International Journal of pharmaceutical research, sponsored by Institute of toxicants and drugs, Chinese Academy of Military Medical Sciences, there was a paper entitled research progress of therapeutic antibodies against Ebola virus, which mentioned:“ In order to provide emergency antibody drugs for China's Ebola epidemic prevention and control and improve the national Ebola epidemic prevention and control capability, the Institute of basic medicine of the Academy of Military Medical Sciences led It has completed the emergency production and reserve task of anti EBOV monoclonal antibody combined injection (mil77), and has the basis for emergency use " According to the paper, the principle of mil77 is similar to zmapp, which is famous in the Ebola epidemic Several Ebola patients recovered after taking zmapp, but the specific efficacy of zmapp still cannot be confirmed The United States has started a large-scale clinical trial of zmapp in February In the medical research, the experimental drugs generally need to go through three phases of clinical trials, in the case of data support, they can be regarded as efficacy confirmed.